Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET IGNITE trial of rocatinlimab, an investigational therapy targeting the OX40 receptor (OX40R) in patients with ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human ...

Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

Kern County officials and the public discussed the recommended budget for fiscal year 2025-2026 on Monday and Tuesday, with a ...

For Suga, artmaking is an exercise in both phenomenology and epistemology, questioning the very “thingness” of a thing.

In designer Michael Villbracht’s 1981 fashion show, Iman matched her multicolor poncho with an eccentric makeup look straight ...

David Shuffler is not a baseball historian. He never worked in the game. He didn’t play, manage or coach; nor has he been ...

Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost ...

Perspective Therapeutics, Inc. ('Perspective” or the 'Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced ...

The artist said that she made the decision after she said she learned that her painting of a transgender Statue of Liberty ...

By integrating clinical and imaging data, providers can better classify and manage migraine, according to an abstract ...